BGB-8035
BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.
Product Specifications
CAS Number
2283349-24-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
453.53
Molecular Formula
C24H31N5O4
Notes
Research use only, not for human use.
Receptor
BTK | EGFR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog